Bespoken Nanoceria: An Effective Treatment in Experimental Hepatocellular Carcinoma

Background and Aims Despite the availability of new‐generation drugs, hepatocellular carcinoma (HCC) is still the third most frequent cause of cancer‐related deaths worldwide. Cerium oxide nanoparticles (CeO2NPs) have emerged as an antioxidant agent in experimental liver disease because of their ant...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Hepatology (Baltimore, Md.) Md.), 2020-10, Vol.72 (4), p.1267-1282
Hauptverfasser:	Fernández‐Varo, Guillermo, Perramón, Meritxell, Carvajal, Silvia, Oró, Denise, Casals, Eudald, Boix, Loreto, Oller, Laura, Macías‐Muñoz, Laura, Marfà, Santi, Casals, Gregori, Morales‐Ruiz, Manuel, Casado, Pedro, Cutillas, Pedro R., Bruix, Jordi, Navasa, Miquel, Fuster, Josep, Garcia‐Valdecasas, Juan Carlos, Pavel, Mihai C., Puntes, Víctor, Jiménez, Wladimiro
Format:	Artikel
Sprache:	eng
Schlagworte:	alpha-Fetoproteins - analysis Animals Antioxidants Apoptosis Apoptosis - drug effects Arachidonic acid Carcinoma, Hepatocellular - drug therapy Cell adhesion Cell adhesion & migration Cerium - pharmacokinetics Cerium - therapeutic use Diethylnitrosamine Gene expression Hepatocellular carcinoma Hepatocytes Hepatology Humans Inflammation Lecithin Linoleic acid Lipid Metabolism - drug effects Liver - metabolism Liver cancer Liver diseases Liver Neoplasms, Experimental - drug therapy Liver Neoplasms, Experimental - mortality Liver Neoplasms, Experimental - pathology Macrophages Male Mass spectroscopy Metastases Nanoparticles Nanoparticles - therapeutic use Original Phosphatidylcholine Phosphorylation Rats Rats, Wistar Ribonucleic acid RNA Signal Transduction - drug effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!